NextCure, Inc.: Promising Growth Potential or Risky Investment? by Mark Eisenberg 28.03.2024 NextCure, Inc. (NXTC) is a biopharmaceutical company focused on novel immunomedicines. Strong financials, positive outlook, and promising pipeline.
Vaccinex Expands Access to ActivMAb Antigen Virus Technology by Lilu Anderson 21.02.2024 ActivMAb's new "Antigen Virus" application complements drug discovery strategies for complex protein targets, according to Vaccinex CEO. Ongoing partnerships can ...